Create issue ticket

221 Possible Causes for Facial Muscle Weakness and Progressive Atrophy, Respiratory Vital Capacity Decreased

  • Distal Spinal Muscular Atrophy Type 3

    Spinal muscular atrophy is characterised by slowly progressive muscle weakness and atrophy of the limb muscles associated with motor neurone loss in the spinal cord.[] Bulbar muscular atrophy affects the bulbar and facial muscles with motor neurone loss in the brainstem. [ 1 ] The spinal muscular atrophies (SMAs) are a spectrum of genetically[] They all result in progressive lower motor neurone weakness. The gene defect is on chromosome 5q and the implicated gene is called survival motor neurone gene 1 (SMN1).[]

  • Spinal and Bulbar Muscular Atrophy

    Abstract Spinal and bulbar muscular atrophy (SBMA) is the first member identified among polyglutamine diseases characterized by slowly progressive muscle weakness and atrophy[] Predicted values of peak expiratory flow (%PEF) and forced vital capacity were decreased in subjects with SBMA compared with controls.[] The main symptoms are slowly progressive muscle weakness and atrophy of bulbar, facial and limb muscles.[]

  • Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1F

    Specifically, LGMD2B is a slowly progressive disease that causes muscle weakness and wasting ( atrophy ) of the pelvic muscles and muscles of the shoulder girdle. 0003236[] […] facial muscle tone Low facial muscle tone Reduced facial muscle tone [ more ] 0000297 Reduced maximal inspiratory pressure 0012496 Reduced vital capacity 0002792 Respiratory[] These diseases affect the voluntary muscles, which are the muscles that are moved on purpose, such as the arms, legs, fingers, toes, and facial muscles.[]

  • Chronic Progressive External Ophthalmoplegia

    PEO6 DNA2 AD PEO w/variable, slowly progressive features; onset: childhood-adulthood Slender build Facial muscle weakness; exertional dyspnea; obstructive sleep apnea; myopathy[] The main finding was decreased respiratory muscle strength, both expiratory (76.8% of predicted, p 0.002) and inspiratory (79.5% of predicted, p 0.004).[] […] w/weakness, atrophy, exercise intolerance, myalgia, & cramps; gait disturbance Elevated CK mtDNA single- nucleotide variants 3 Selected example: m.3243A G 4 MT-TL1 Mat Headaches[]

  • Neuromuscular Junction Disorder

    Signs: there is ptosis, facial weakness, atrophy of the sternocieidomastoid muscles, cataracts, and decreased intelligence.[] The former is most reproducibly monitored at the bedside by serial measurements of forced vital capacity (FVC).[] Patients present in adult life with particular symptoms: Myotonic: Difficulty with releasing grip Dystrophic: Weakness of the distal muscles of the arms and legs.[]

  • Acute Respiratory Infection

    As consolidation takes place, the respiratory function alters the vital capacity and the distensibility of the airways decreases.[] The blood flow and ventilation of the involved areas is affected, altering the ventilation/perfusion relationship and resulting in decreased oxygenation and increased respiratory[]

    Missing: Facial Muscle Weakness and Progressive Atrophy
  • Pregnancy

    Expiratory reserve volume (ERV) decreases 15%. Residual volume decreases. Vital capacity does not change. Inspiratory capacity increases 5%.[] The following is a summary of respiratory changes in pregnancy [7] : Respiratory rate does not change. Tidal volume increases 0.1-0.2 L, about 40%.[]

    Missing: Facial Muscle Weakness and Progressive Atrophy
  • Allergic Asthma

    Patients of young age tend to have elevated forced vital capacity, which might decrease the ratio of FEV1/FVC without necessarily signifying an obstruction.[] A ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) that is less than 70% defines respiratory obstruction.[]

    Missing: Facial Muscle Weakness and Progressive Atrophy
  • Pulmonary Edema

    A typical pattern of respiratory mechanics for a patient with residual pulmonary edema includes decreases in vital capacity and total lung capacity.[] They may be obtained after respiratory stabilization to establish baseline pulmonary function.[]

    Missing: Facial Muscle Weakness and Progressive Atrophy
  • Hypoxia

    , forced vital capacity and FEV 1 were decreased in 67% and 30% of individuals, respectively.[] Restrictive physiology and a low DLco have been described as the predominant pattern. 91, 92 In a cross-sectional study of 49 patients with BT without respiratory symptoms[]

    Missing: Facial Muscle Weakness and Progressive Atrophy

Further symptoms